Showing results (411-420 of 469) with videos related to

Sort By:
Pageof 47
Nephron. Clinical Practice|July 29, 2010
Global evolutionary trend of the prevalence of primary glomerulonephritis over the past three decadesKeng-Thye Woo, Choong-Meng Chan, Yoke Mooi Chin, et al.
Breast Cancer Research and Treatment|June 22, 2018
Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotypeYoon-Sim Yap, Prabhakaran Munusamy, Cindy Lim, et al.
Oncotarget|March 17, 2018
Using computer assisted image analysis to determine the optimal Ki67 threshold for predicting outcome of invasive breast cancerTimothy Kwang Yong Tay, Aye Aye Thike, Nirmala Pathmanathan, et al.
Cancer Medicine|October 4, 2015
Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1John Richard McPherson, Choon-Kiat Ong, Cedric Chuan-Young Ng, et al.
Breast (Edinburgh, Scotland)|October 23, 2012
Do primary mammary osteosarcoma and chondrosarcoma exist? A review of a large multi-institutional series of malignant matrix-producing breast tumoursEmad A Rakha, Puay Hoon Tan, Abeer Shaaban, et al.
Cureus|March 6, 2026
Therapeutic and Diagnostic Landscape of Diabetic Neuropathy: A Systematic Review of Clinical StudiesJay Prakash S Rajput, Rahul Deb, Sajidali S Saiyad, et al.
Nature Chemical Biology|August 3, 2026
Computational design of antimicrobial peptide nanoporesRahul Deb, Marcelo D T Torres, Ivo Kabelka, et al.
Kidney Diseases (Basel, Switzerland)|September 14, 2020
The Value of Renal Biopsy in Non-Insulin-Dependent Diabetes Mellitus in Singapore over the Past Two DecadesKeng Thye Woo, Choong Meng Chan, Cynthia Lim, et al.
The American Journal of Surgical Pathology|June 14, 2013
Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistryDavid J Dabbs, Stuart J Schnitt, Felipe C Geyer, et al.
Cell Death Discovery|September 28, 2021
Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancersSer Yue Loo, Nicholas L Syn, Angele Pei-Fern Koh, et al.
Pageof 47